Experience

Biomeme, Inc.

• United States
• Biotechnology Research
• 1 - 100 Employee

• Board Member

  • Sep 2021 - Present



BestBio Consulting

• United States
• Business Consulting and Services

• President

  • Jun 2012 - Present

  Providing strategic advisory services in a variety of healthcare-related fields, including precision medicine, clinical trial operations, and product commercialization in healthcare. Providing strategic advisory services in a variety of healthcare-related fields, including precision medicine, clinical trial operations, and product commercialization in healthcare.



Predigen Inc

• United States
• Biotechnology

• Co-Founder, CEO

  • Sep 2016 - Sep 2021

  CEO of Predigen, a Duke University spin out that is a global leader in the development of host gene expression signatures for use as prognostic, diagnostic, and therapeutic monitoring tools. Acquired by Biomeme, 2021. CEO of Predigen, a Duke University spin out that is a global leader in the development of host gene expression signatures for use as prognostic, diagnostic, and therapeutic monitoring tools. Acquired by Biomeme, 2021.



Childhood Arthritis and Rheumatology Research Alliance (CARRA) Inc.

• Raleigh-Durham, North Carolina Area

• Chief Business Officer

  • Jan 2014 - Jun 2017

  Facilitated development of not-for-profit research organization devoted to improving the lives of children diagnosed with pediatric rheumatic diseases. Led team to secure > $40 million in capital to support implementation of numerous clinical and translational research programs. Facilitated development of not-for-profit research organization devoted to improving the lives of children diagnosed with pediatric rheumatic diseases. Led team to secure > $40 million in capital to support implementation of numerous clinical and translational research programs.



Ariste Medical, LLC

• Medical Equipment Manufacturing
• 1 - 100 Employee

• Co-Founder, CEO

  • Aug 2007 - Aug 2015

  Founded company, managed licensing of drug-device intellectual property, facilitated USPTO filing to achieve patent issuance (2012 & 2014), developed business plan, raised seed capital (2012) and series A (2015) funding, and initiated strategic plan for development of drug eluting mesh for surgical repair of hernia, resulting in 510(k) FDA submission in 2021. Founded company, managed licensing of drug-device intellectual property, facilitated USPTO filing to achieve patent issuance (2012 & 2014), developed business plan, raised seed capital (2012) and series A (2015) funding, and initiated strategic plan for development of drug eluting mesh for surgical repair of hernia, resulting in 510(k) FDA submission in 2021.



Navigant

• United States
• Business Consulting and Services
• 700 & Above Employee

• Director, Life Sciences Consulting

  • Jul 2011 - May 2012

  Providing consulting services to support small and large drug, device and diagnostic companies in commercial planning, product development, and strategy formulation. Developing and leading team of seasoned professionals to expand capabilities to western market. Providing consulting services to support small and large drug, device and diagnostic companies in commercial planning, product development, and strategy formulation. Developing and leading team of seasoned professionals to expand capabilities to western market.



Tethys Bioscience, Inc.

• United States
• Biotechnology Research
• 1 - 100 Employee

• Sr. Vice President, Marketing & Medical Affairs

  • Oct 2010 - Jun 2011

  Member of Management Team, responsible for developing Medical Affairs capability while creating and implementing strategic plan to define future of company and support additional venture capital investment.

• Vice President of Commercial Operations

  • May 2008 - Oct 2010

  Responsible for developing all commercial functions, including marketing, sales, and operations, for US launch of novel molecular diagnostic product in diabetes and cardiometabolic markets (primary care).



Medicure

• Canada
• Pharmaceutical Manufacturing
• 1 - 100 Employee

• Senior Advisor

  • May 2008 - Oct 2010

  Served as consultant to support sales, marketing, and medical affairs strategy for Medicure, post-failure of P3 study of MC-1. Provided strategic and tactical guidance for US marketing and worldwide deals relating to the commercialized product Aggrastat.

• Vice President, Sales and Marketing

  • Aug 2007 - May 2008

  Responsible for development of the sales/marketing/medical affairs organization, strategy, tactics, budget, and general commercial planning in support of the launch plan for the late stage cardioprotective agent MC-1, and the commercialized product Aggrastat. (MC-1 failed P3 trial in early 2008.)



PDL Biopharma & Portola Pharmaceuticals

• San Francisco Bay Area

• Consultant, Commercial and Clinical Strategy

  • Sep 2006 - Sep 2007

  Provided consulting services for various biotech organizations seeking clinical and commercial expertise. - Strategic assessment of pipeline assets to determine optimal partnering/licensing strategy. - Market research to establish therapeutic landscape and customer segmentation. - Scenario planning to assess market evolution using scientific advisors and competitive intelligence. - Development of outcomes registry to inform clinical strategy. Provided consulting services for various biotech organizations seeking clinical and commercial expertise. - Strategic assessment of pipeline assets to determine optimal partnering/licensing strategy. - Market research to establish therapeutic landscape and customer segmentation. - Scenario planning to assess market evolution using scientific advisors and competitive intelligence. - Development of outcomes registry to inform clinical strategy.



American College of Cardiology

• United States
• Hospitals and Health Care
• 400 - 500 Employee

• Consultant

  • Sep 2005 - Sep 2007

  Employed as Consultant by the ACC to facilitate strategic planning for multiple national registry programs, including the acquisition of the NRMI registry from Genentech and the multi-sponsored CRUSADE registry to create the largest national cardiovascular database in the US. Registry work includes CARE (carotid revascularization registry), ACTION (ACS QI registry), Congenital registry, Imaging registry, and more. Employed as Consultant by the ACC to facilitate strategic planning for multiple national registry programs, including the acquisition of the NRMI registry from Genentech and the multi-sponsored CRUSADE registry to create the largest national cardiovascular database in the US. Registry work includes CARE (carotid revascularization registry), ACTION (ACS QI registry), Congenital registry, Imaging registry, and more.



Arginox Pharmaceuticals

• Pharmaceutical Manufacturing
• 1 - 100 Employee

• Sr. Director, Clinical Affairs

  • Sep 2005 - Aug 2006

  Responsible for hiring and managing Clinical Trial Liaison team to facilitate execution of phase 3 study, and for pre-launch commercial and clinical affairs planning, development, and activities. Responsible for hiring and managing Clinical Trial Liaison team to facilitate execution of phase 3 study, and for pre-launch commercial and clinical affairs planning, development, and activities.



Takeda Oncology

• United States
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Director, Medical Affairs

  • Jan 2005 - Aug 2005

  Led the Global Medical Affairs organization to optimize brand medical support and to develop Millennium’s first Medical Science Liaison (MSL) group.

• Director, National Clinical Specialists

  • Jul 2004 - Dec 2004

  Resonsible for specialty/clinical sales organization and for executing sales and marketing collaboration with new European partner, GSK.

• Director of Marketing

  • Apr 2003 - Jun 2004

  Responsible for management of the INTEGRILIN brand ($400MM) and for managing the commercial partnership between Millennium and Schering.



Cor Therapeutics

• United States
• Pharmaceutical Manufacturing

• Product Director

  • Feb 2002 - Mar 2003

  Responsible for leading marketing activities for INTEGRILIN, and managed the development and implementation of new 67-person sales force.

• Sr. Marketing Manager

  • Feb 2001 - Jan 2002

  Responsible for leading marketing activities for INTEGRILIN, and developed CRUSADE, the National Quality Improvement Initiative driving awareness and adoption of the ACC/AHA Guidelines, supported and coordinated by the Duke Clinical Research Institute (DCRI).

• Marketing Manager

  • Mar 2000 - Jan 2001

• Hospital Sales Representative

  • Jan 1998 - Feb 2000



Abbott

• United States
• Hospitals and Health Care
• 700 & Above Employee

• Specialty Sales Representative

  • Jan 1992 - Jan 1998